MarketCap
Facebook
X
TelegramOxford Immunotec Global PLC DSO Ratio 2011-2026 | OXFD
Annual DSO Ratio Oxford Immunotec Global PLC
| 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|
| - | 90.8 | 83.4 | 60.1 | 56.2 | 41 | 50.3 | 44.7 | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 90.8 | 41 | 60.9 |
DSO Ratio of other stocks in the Diagnostics research industry
| Issuer | DSO Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Centogene N.V.
CNTG
|
145 | - | -6.23 % | $ 30.6 M |  Germany |
 |
Agilent Technologies
A
|
63.8 | $ 121.37 | 0.83 % | $ 36.9 B |  USA |
 |
Burning Rock Biotech Limited
BNR
|
31.7 | $ 20.3 | 2.06 % | $ 218 M |  China |
 |
Aspira Women's Health
AWH
|
1.17 K | - | -6.19 % | $ 10.5 M | USA |
 |
Biocept
BIOC
|
112 | - | -13.05 % | $ 7.29 M | USA |
 |
Chembio Diagnostics
CEMI
|
66.3 | - | 0.22 % | $ 16.8 M | USA |
 |
CareDx, Inc
CDNA
|
51.5 | $ 17.75 | 0.68 % | $ 946 M | USA |
 |
DermTech
DMTK
|
80.6 | - | -11.32 % | $ 2.94 M | USA |
|
Akumin
AKU
|
57.4 | - | -17.87 % | $ 25.9 M |  Canada |
 |
Enzo Biochem
ENZ
|
50.3 | - | -8.98 % | $ 14.8 K | USA |
 |
Co-Diagnostics
CODX
|
94.7 | $ 1.39 | 0.72 % | $ 1.85 M | USA |
 |
Exact Sciences Corporation
EXAS
|
30.8 | - | - | $ 19.8 B | USA |
 |
Accelerate Diagnostics
AXDX
|
291 | - | -61.36 % | $ 2.46 M | USA |
 |
Castle Biosciences
CSTL
|
49.2 | $ 24.59 | 0.91 % | $ 683 M | USA |
 |
Global Cord Blood Corporation
CO
|
112 | - | - | $ 399 M | China |
 |
Fluidigm Corporation
FLDM
|
67.2 | - | 1.08 % | $ 308 M | USA |
 |
Genetic Technologies Limited
GENE
|
11.7 K | - | - | $ 7.1 B |  Australia |
 |
Genetron Holdings Limited
GTH
|
122 | - | 0.12 % | $ 80.1 M | China |
 |
Charles River Laboratories International
CRL
|
65 | $ 183.31 | 2.23 % | $ 9.09 B | USA |
 |
PRA Health Sciences, Inc.
PRAH
|
98.1 | - | - | $ 10.7 B | USA |
 |
Medpace Holdings
MEDP
|
50.4 | $ 521.18 | 0.23 % | $ 15 B | USA |
 |
Interpace Biosciences
IDXG
|
66.9 | $ 2.2 | - | $ 9.73 M | USA |
 |
Danaher Corporation
DHR
|
55.3 | $ 198.94 | 0.21 % | $ 142 B | USA |
 |
Heska Corporation
HSKA
|
40.8 | - | - | $ 1.31 B | USA |
 |
HTG Molecular Diagnostics
HTGM
|
101 | - | -20.0 % | $ 1.06 M | USA |
 |
Illumina
ILMN
|
61.3 | $ 131.54 | 0.94 % | $ 20.9 B | USA |
 |
NeoGenomics
NEO
|
77.7 | $ 8.63 | 3.35 % | $ 1.11 B | USA |
 |
Natera
NTRA
|
81.5 | $ 211.22 | -1.59 % | $ 20.8 B | USA |
 |
Fulgent Genetics
FLGT
|
77.4 | $ 16.2 | 1.15 % | $ 490 M | USA |
 |
Motus GI Holdings
MOTS
|
77.2 | - | -34.28 % | $ 263 K |  Israel |
 |
Guardant Health
GH
|
46.1 | $ 85.92 | -0.56 % | $ 10.8 B | USA |
 |
QIAGEN N.V.
QGEN
|
30.8 | - | - | $ 10.6 B |  Niderland |
 |
Myriad Genetics
MYGN
|
52.3 | $ 5.14 | 4.58 % | $ 476 M | USA |
 |
Anixa Biosciences
ANIX
|
275 | $ 2.8 | -2.95 % | $ 90.9 K | USA |
 |
Biomerica
BMRA
|
57.7 | $ 2.11 | 0.48 % | $ 4.85 M | USA |
 |
Senseonics Holdings
SENS
|
10.3 | $ 6.85 | 1.48 % | $ 286 M | USA |
 |
ICON Public Limited Company
ICLR
|
68.5 | $ 113.78 | 0.64 % | $ 9.38 B |  Irlanda |
 |
Laboratory Corporation of America Holdings
LH
|
52.9 | $ 268.92 | 0.03 % | $ 22.4 B | USA |
 |
Soleno Therapeutics
SLNO
|
27 | $ 52.61 | -0.03 % | $ 2.67 B | USA |
 |
Neogen Corporation
NEOG
|
66.6 | $ 9.49 | -1.25 % | $ 2.06 B | USA |
 |
Lantheus Holdings
LNTH
|
80.5 | $ 83.07 | 0.4 % | $ 5.61 B | USA |
 |
Neuronetics
STIM
|
48.7 | $ 1.43 | -0.35 % | $ 94.3 M | USA |
 |
Quest Diagnostics Incorporated
DGX
|
44.9 | $ 192.82 | -0.63 % | $ 21.4 B | USA |
 |
ENDRA Life Sciences
NDRA
|
7.11 | $ 5.05 | 1.81 % | $ 3.97 M | USA |
 |
Thermo Fisher Scientific
TMO
|
70 | $ 527.38 | 0.02 % | $ 199 B | USA |
 |
Trinity Biotech plc
TRIB
|
87.2 | $ 0.71 | -0.27 % | $ 61.9 M | Irlanda |